PharmaZac sponsors the medical book “Epilepsy and Movement Disorders”
July 4, 2023
We are investing in our new pharmaceuticals manufacturing site.
November 2, 2023Pharmazac launched the new product Etrozac / etoricoxib.
Pharmazac launched Etrozac / etoricoxib a selective cyclo-oxygenase – 2 (COX-2) inhibitor.
Etrozac indicated for the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain and the pain sings of inflammation associated with acute gouty arthritis.